...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles.
【24h】

HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles.

机译:来自恶性疟原虫前红细胞阶段抗原的HLA-DR混杂T细胞表位受多个HLA II类等位基因限制。

获取原文
获取原文并翻译 | 示例
           

摘要

Previously, we identified and established the antigenicity of 17 CD8+ T cell epitopes from five P. falciparum Ags that are restricted by multiple common HLA class I alleles. Here, we report the identification of 11 peptides from the same Ags, cicumsporozoite protein, sporozoite surface protein 2, exported protein-1, and liver-stage Ag-1, that bind between at least five and up to 11 different HLA-DR molecules representative of the most common HLA-DR Ags worldwide. These peptides recall lymphoproliferative and cytokine responses in immune individuals experimentally immunized with radiation-attenuated Plasmodium falciparum sporozoites (irradiated sporozoites) or semi-immune individuals naturally exposed to malaria in Irian Jaya or Kenya. We establish that all peptides are recognized by individuals of each of the three populations, and that the frequency and magnitude of helper T lymphocyte responses to each peptide is influenced by the intensity of exposure to P. falciparum sporozoites. Mean frequencies of lymphoproliferative responses are 53.2% (irradiated sporozoites) vs 22.4% (Kenyan) vs 5.8% (Javanese), and mean frequencies of IFN-gamma responses are 66.3% (irradiated sporozoites) vs 27.3% (Kenyan) vs 8. 7% (Javanese). The identification of HLA class II degenerate T cell epitopes from P. falciparum validates our predictive strategy in a biologically relevant system and supports the potential for developing a broadly efficacious epitope-based vaccine against malaria focused on a limited number of peptide specificities.
机译:以前,我们从五个受多个常见的HLA I类等位基因限制的恶性疟原虫Ags中鉴定并建立了17个CD8 + T细胞表位的抗原性。在这里,我们报告了11种肽的鉴定,这些肽来自相同的Ag,环孢子蛋白,子孢子表面蛋白2,输出蛋白1和肝期Ag-1,它们结合至少5至11种不同的HLA-DR分子全球最常见的HLA-DR Ags的代表。这些肽可回忆起在以免疫减毒的恶性疟原虫子孢子(辐射的子孢子)进行实验性免疫的免疫个体中的免疫反应,或在Irian Jaya或肯尼亚自然暴露于疟疾的半免疫个体的淋巴增生和细胞因子反应。我们建立了所有的肽被三个人口中的每个人口的个人识别,并且辅助T淋巴细胞对每个肽的反应的频率和大小受恶性疟原虫子孢子暴露强度的影响。淋巴增生反应的平均频率为53.2%(辐射的子孢子),22.4%(肯尼亚),5.8%(爪哇),IFN-γ反应的平均频率为66.3%(辐射的子孢子),27.3%(肯尼亚)和8. 7。 %(Javanese)。从恶性疟原虫鉴定HLA II类简并T细胞表位验证了我们在生物学相关系统中的预测策略,并支持了开发针对疟疾的广泛有效的基于表位的疫苗的潜力,该疫苗侧重于有限的肽特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号